Target intelligence / Profile preview

Bacterial Krebs cycle enzyme

Molecular classification
Enzyme
01

Overview

Bacterial Krebs cycle enzymes are central metabolic enzymes that catalyze the sequential reactions of the tricarboxylic acid (TCA) cycle, also known as the citric acid cycle or Krebs cycle, which is a universal pathway for oxidative energy production in aerobic organisms. The main enzymes include citrate synthase, aconitase, isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, succinyl-CoA synthetase, succinate dehydrogenase, fumarase, and malate dehydrogenase[1][3]. In bacteria, these enzymes operate in the cytoplasm and are essential for cellular respiration, enabling the efficient extraction of energy from organic substrates via NADH and FADH₂ production, feeding electrons to the electron transport chain for ATP synthesis[3][9]. Because of their essentiality, several bacterial Krebs cycle enzymes have been proposed as antibacterial drug targets, particularly in pathogens where TCA cycle activity is linked to antibiotic susceptibility and virulence[2][6]. However, the target as stated ("Bacterial Krebs cycle enzymes") is not a single molecule but a plural, functionally related enzyme family. Specific enzymes (like isocitrate dehydrogenase or succinate dehydrogenase) are more suitable as canonical singular targets for structured information. Note: - The provided name is not a specific molecular target, but rather describes a **class** of enzymes. For best practices in drug discovery or database structuring, each enzyme (e.g., "Bacterial succinate dehydrogenase") should be considered individually for canonical naming. - Enzyme inhibitors must be selective for the bacterial form to minimize eukaryotic toxicity. - TCA cycle modulation is under investigation as a strategy for potentiating antibiotics and attenuating bacterial pathogenicity[2][6]. This entry is **non-canonical** as written ("Bacterial Krebs cycle enzymes" is a class, not a molecule) and should be subdivided for database use.

Other names
Krebs cycle enzyme (bacterial)Tricarboxylic acid (TCA) cycle enzyme (bacterial)Citric acid cycle enzyme (bacterial)
02

Mechanism of action

Enzyme inhibition (e.g., succinate dehydrogenase inhibition by malonate). Metabolic modulation (metabolite supplementation increases respiration and potentiates antibiotics). Indirect bactericidal enhancement (augmenting TCA cycle activity to increase sensitivity to antibiotics via altered redox status and membrane potential).

03

Biological functions

Energy production (ATP generation)Central metabolism/intermediary metabolismElectron transfer and respirationRegulation of metabolic flux
04

Disease associations

Infection (bacterial pathogens)Antibacterial targetDrug resistance (aspects of antibiotic tolerance in bacteria)Other (potential role in metabolic adaptation, not direct implication in non-infectious diseases)
05

Safety considerations

Essentiality for host cell metabolism (homologs exist in mitochondria of eukaryotes, risk of off-target toxicity if not bacterial-specific)Compensatory metabolic pathways (bacteria can sometimes bypass TCA cycle enzymes, risks for resistance or tolerance)
06

Interacting drugs

Rotenone

2 more in the full profile.

07

Biomarkers

Accumulation or depletion of cycle intermediates (e.g., citrate, succinate) may reflect metabolic state or response to inhibitorsEnzyme activity measurements (e.g., decreased succinate dehydrogenase activity as a surrogate for oxidative stress or drug action)

Beyond the preview

Go deeper on Bacterial Krebs cycle enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial Krebs cycle enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call